Psychiatry and Neurology, Neurology · Moore, OK
NPI
1992819700
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1060 SW 4th St
Moore, OK, 73160
Phone (405) 302-2661
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
15,686 services
Medicare patients, 2024
339
Average age 72
Drug cost, 2024
$2.3M
1,282 prescriptions
Company payments, 2025
$95K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eduardo A de Sousa was code J0585 (injection, onabotulinumtoxina, 1 unit), 14,755 times for 25 patients. In total Eduardo A de Sousa billed 15,686 services in 28 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 14,755 | 25 | $4.56 | $67K |
| 95886 Electrical Nerve Conductivity | Office | 179 | 117 | $68.42 | $12K |
| 99214 Office E&M - Established | Office | 173 | 119 | $80.52 | $14K |
| 95885 Electrical Nerve Conductivity | Office | 78 | 54 | $40.98 | $3,197 |
| 99215 Office E&M - Established | Office | 64 | 56 | $122.26 | $7,824 |
| 95913 Electrical Nerve Conductivity | Office | 59 | 59 | $190.99 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 50 | 48 | $12.29 | $615 |
| 95911 Electrical Nerve Conductivity | Office | 48 | 48 | $140.07 | $6,723 |
| 95910 Electrical Nerve Conductivity | Office | 38 | 38 | $103.08 | $3,917 |
| 64615 Musculoskeletal | Office | 38 | 14 | $96.94 | $3,684 |
| 36415 Venipuncture Blood Collection | Office | 32 | 28 | $8.65 | $277 |
| 95874 Musculoskeletal | Office | 28 | 12 | $51.38 | $1,439 |
| 99213 Office E&M - Established | Office | 24 | 22 | $53.82 | $1,292 |
| 95912 Electrical Nerve Conductivity | Office | 23 | 23 | $159.46 | $3,668 |
| 99205 Office E&M - New | Office | 19 | 19 | $151.08 | $2,870 |
By year: 2022 $196K for 21,588 services; 2023 $148K for 14,123 services; 2024 $146K for 15,686 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 32 | 28 | $8.65 | $277 |
Medicare prescription drug claims, 2024
In 2024, the drug Eduardo A de Sousa prescribed most often to Medicare patients was Gabapentin, with 112 prescriptions and refills. In total Eduardo A de Sousa wrote 1,282 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 112 | 272 | 35 | $2,728 |
| Pregabalin Generic | 105 | 229 | 27 | $2,311 |
| Pyridostigmine Bromide Generic | 96 | 176 | 27 | $7,831 |
| Mycophenolate Mofetil Generic | 63 | 152 | 16 | $9,648 |
| Prednisone Generic | 58 | 115 | 19 | $541 |
| Sumatriptan Succinate Generic | 55 | 65 | Under 11 | $776 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 53 | 53 | Under 11 | $153K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 45 | 103 | 17 | $3,000 |
| Rytary Carbidopa/Levodopa | 37 | 65 | Under 11 | $57K |
| Amitriptyline Hcl Generic | 35 | 70 | Under 11 | $381 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 33 | 33 | Under 11 | $856K |
| Duloxetine Hcl Generic | 30 | 80 | 12 | $1,610 |
| Sodium Chloride 0.9 % Sodium Chloride | 28 | 28 | Under 11 | $91.58 |
| Nortriptyline Hcl Generic | 28 | 66 | Under 11 | $764 |
| Donepezil Hcl Generic | 25 | 53 | Under 11 | $649 |
Brand drugs: 273 claims; generic drugs: 1,009 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eduardo A de Sousa $95K ($95K in general payments such as food, travel and fees) from 17 companies. The largest payer was Argenx US, Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 19 | $23K |
| Janssen Biotech, Inc. JNJ | 24 | $20K |
| UCB, Inc. UCB.BR | 17 | $17K |
| Amgen Inc. AMGN | 11 | $11K |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $9,058 |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $7,080 |
| CSL Behring CSL.AX | 13 | $6,965 |
| Abbott Laboratories ABT | 1 | $71.2 |
| Pfizer Inc. PFE | 3 | $70.72 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $48.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.